✦ LIBER ✦

Abnormal proteolytic degradation of von willebrand factor after desmopressin infusion in a new subtype of von willebrand disease (ID)

✍ Scribed by M. F. Lopez-Fernandez; R. Gonzalez-Boullosa; M. J. Blanco-Lopez; M. Perez; J. Batlle

Publisher: John Wiley and Sons
Year: 1991
Tongue: English
Weight: 883 KB
Volume: 36
Category: Article
ISSN: 0361-8609
DOI: 10.1002/ajh.2830360302

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

New variant of type II von willebrand's

New variant of type II von willebrand's disease with structural abnormality of plasma von willebrand factor in a patient with very mild bleeding history

✍ Peter Baillod; Christine Gaucher; Beat Affolter; Claudine Mazurier; Rolf Pflugsh 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 749 KB

Type II H von willebrand disease: New st

Type II H von willebrand disease: New structural abnormality of plasma and platelet von willebrand factor in a patient with prolonged bleeding time and borderline levels of ristocetin cofactor activity

✍ Dr. Augusto B. Federici; Pier Mannuccio Mannucci; Rossana Lombardi; Antonella La 📂 Article 📅 1989 🏛 John Wiley and Sons 🌐 English ⚖ 769 KB

Retrospective review of the management o

Retrospective review of the management of elective surgery with desmopressin and clotting factor concentrates in patients with von Willebrand disease

✍ Ioana C. Nitu-Whalley; Anja Griffioen; Chris Harrington; Christine A. Lee 📂 Article 📅 2001 🏛 John Wiley and Sons 🌐 English ⚖ 32 KB 👁 2 views

## Abstract Limited data are available regarding optimal treatment with desmopressin (DDAVP) or intermediate‐purity FVIII concentrates rich in VWF (CFCs) in patients with von Willebrand disease (VWD) who undergo planned surgery. We undertook a retrospective review over 10 years (1988–1997) and iden